Key result
Endothelial progenitor cells inversely correlate with cardiovascular risk factors, serving as a potential surrogate marker for cardiovascular risk and a therapeutic target for vascular diseases.
Endothelial progenitor cells hold promise both as a diagnostic biomarker for vascular dysfunction and as a potential therapeutic target for various vascular diseases.
No takes yet. Share an insight, caveat, or question.
EPCs may indicate vascular risk but should not yet alter management; leaves open prospective validation as biomarkers and targets.
Liew et al. (2006) conducted a review in Cardiovascular disease. Endothelial progenitor cells was evaluated. Endothelial progenitor cells inversely correlate with cardiovascular risk factors, serving as a potential surrogate marker for cardiovascular risk and a therapeutic target for vascular diseases.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: